Скачать или смотреть Lab to Life: The Path to Successful Biotechnology Commercialization

Author: Anton Papa, M.S. in Biotechnology Management and Entrepreneurship
Faculty Advisor: Nilam Sinha, Ph.D., Albert Einstein College of Medicine

Abstract:
Important biotechnology inventions that promise to improve human life often fail to make it to market due to stakeholders facing numerous challenges related to regulatory hurdles, funding constraints and intellectual property (IP) rights. In partnership with Albert Einstein College of Medicine's Office of Biotechnology and Business Development (OBBD), this project explores the commercialization potential and requirements for three novel biotechnology inventions: 1) A storage and preservation solution that minimizes damage and prolongs function of donated biologicals tissue and organ (Project C-00001470); 2) A precision, small molecule therapy for patients with Type I Diabetes (Project C-00001455); and 3) A small molecule cancer therapeutic that targets RICTOR for brain metastasis from lung cancers and overcomes anti-EGFR drug resistance (Project C-00001352). The project includes outlining the commercialization strategy for each technology, including reviewing intellectual property and invention disclosure provided by the primary investigator; drafting of non-confidential marketing summaries; market research; identifying potential licensing partners; and drafting marketing campaigns. In addition, this project also provides valuable insights of the technology transfer lifecycle for investors and stakeholders interested in the commercialization of biotech inventions.